Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
Osteosarcoma (OS) is the most common primary bone tumor, mainly occurring in children and adolescents. Current standard therapy includes tumor resection associated with multidrug chemotherapy. However, patient survival has not evolved for the past decades. Since the 1970s, the 5-year survival rate i...
Main Authors: | Louise Marchandet, Morgane Lallier, Céline Charrier, Marc Baud’huin, Benjamin Ory, François Lamoureux |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/683 |
Similar Items
-
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
by: Morgane Lallier, et al.
Published: (2021-03-01) -
Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01) -
Osteosarcoma with atypical location in an elderly female patient
by: Daniel Cury Ogata, et al.
Published: (2011-12-01) -
Chemotherapy in the management of periosteal osteosarcoma: A narrative review
by: Tarek Assi, et al.
Published: (2021-10-01) -
Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
by: Yong Bicheng, et al.
Published: (2012-09-01)